Connected drug delivery devices market to grow to $4bn by 2028
A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices.
List view / Grid view
A new report reveals the COVID-19 pandemic, prevalence of chronic disease and increasing patient engagement will all drive adoption of connected drug delivery devices.
Outsourcing has become more popular with pharmaceutical companies, and has led to work being completed quicker, with less effort and cost involved...
The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a report by Grand View Research, Inc...